论文部分内容阅读
血管紧张素Ⅱ受体阻滞剂(ARB)自上个世纪90年代中期应用于临床高血压治疗以来,其有效性和突出的安全性得到临床医生和广大患者的普遍认可。大量的临床试验显示,ARB不仅是治疗高血压
Since its application to clinical treatment of hypertension in the mid-1990s, angiotensin Ⅱ receptor blocker (ARB) has been widely accepted by clinicians and the general public for its effectiveness and outstanding safety. A large number of clinical trials show that ARB is not only for the treatment of hypertension